Universe · entity
Avidity Partners Management LP
Institutional manager (13F) · CIK 1791827
13F holdings · as of 2026-03-31 · top 46 · reported portfolio $442M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | DIANTHUS THERAPEUTICS INC | $185M | 2,104,184 |
| 2 | ORUKA THERAPEUTICS INC | $52M | 760,424 |
| 3 | JADE BIOSCIENCES INC | $34M | 1,400,708 |
| 4 | PERSPECTIVE THERAPEUTICS INC | $24M | 6,049,999 |
| 5 | ENLIVEN THERAPEUTICS INC | $16M | 400,000 |
| 6 | CONTEXT THERAPEUTICS INC | $12M | 4,998,267 |
| 7 | REPLIGEN CORP | $9M | 77,800 |
| 8 | PALVELLA THERAPEUTICS INC NE | $9M | 70,000 |
| 9 | AKTIS ONCOLOGY INC | $9M | 468,566 |
| 10 | MEDTRONIC PLC | $8M | 100,000 |
| 11 | TEVA PHARMACEUTICAL INDS LTD | $7M | 200,000 |
| 12 | IMMUNIC INC | $6M | 669,941 |
| 13 | VIR BIOTECHNOLOGY INC | $6M | 619,300 |
| 14 | DEXCOM INC | $6M | 100,000 |
| 15 | HUMANA INC | $6M | 25,000 |
| 16 | ENCOMPASS HEALTH CORP | $4M | 42,000 |
| 17 | KARYOPHARM THERAPEUTICS INC | $4M | 463,741 |
| 18 | TEMPUS AI INC | $4M | 65,000 |
| 19 | TENAX THERAPEUTICS INC | $3M | 265,934 |
| 20 | BOSTON SCIENTIFIC CORP | $3M | 60,000 |
| 21 | SATELLOS BIOSCIENCE INC | $3M | 387,769 |
| 22 | PHATHOM PHARMACEUTICALS INC | $3M | 249,390 |
| 23 | GILEAD SCIENCES INC | $3M | 20,000 |
| 24 | STRUCTURE THERAPEUTICS INC | $2M | 48,000 |
| 25 | SCYNEXIS INC | $2M | 2,081,660 |
| 26 | ICON PLC | $2M | 16,000 |
| 27 | NATERA INC | $2M | 9,000 |
| 28 | CORVUS PHARMACEUTICALS INC | $2M | 115,000 |
| 29 | INSULET CORP | $2M | 10,000 |
| 30 | CHARLES RIV LABS INTL INC | $2M | 10,000 |
| 31 | CORCEPT THERAPEUTICS INC | $1M | 30,000 |
| 32 | HIMS & HERS HEALTH INC | $1M | 50,000 |
| 33 | GENMAB A/S | $1M | 50,000 |
| 34 | PELOTON INTERACTIVE INC | $1M | 200,000 |
| 35 | INTELLIA THERAPEUTICS INC | $1M | 75,000 |
| 36 | ODDITY TECH LTD | $1M | 70,000 |
| 37 | ANTERIS TECHNOLOGIES GLOBAL | $923k | 150,000 |
| 38 | ABBOTT LABORATORIES | $908k | 10,000 |
| 39 | MOONLAKE IMMUNOTHERAPEUTICS | $819k | 50,000 |
| 40 | BRIDGEBIO PHARMA INC | $711k | 10,000 |
| 41 | ARBUTUS BIOPHARMA CORP | $525k | 125,000 |
| 42 | BRIDGEBIO ONCOLOGY THERAPEUT | $369k | 43,853 |
| 43 | LEGEND BIOTECH CORP | $353k | 15,000 |
| 44 | ACADIA PHARMACEUTICALS INC | $291k | 12,967 |
| 45 | SAVARA INC | $262k | 50,000 |
| 46 | TREVI THERAPEUTICS INC | $92k | 6,660 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.